China: Meinian sells US$200m two-year at 7.75%

Meinian Onehealth Healthcare, the second largest healthcare provider in China, has sold a US$200m two-year Reg S at 7.75% – its first bond in the international markets. The April 2021s priced at 98.647 to yield 8.5%. Price talk for the fixed rate senior unsecured paper was at the high 8% level before price guidance went…

You must be a HMI Subscriber to view this content.

Subscribe Now »